company background image
ALECR logo

Eurofins-Cerep ENXTPA:ALECR Stock Report

Last Price

€23.00k

Market Cap

€116.0m

7D

0%

1Y

n/a

Updated

26 Mar, 2024

Data

Company Financials

ALECR Stock Overview

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

ALECR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Eurofins-Cerep SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Eurofins-Cerep
Historical stock prices
Current Share Price€23,000.00
52 Week High€29,200.00
52 Week Low€22,200.00
Beta0.58
1 Month Change0%
3 Month Change-8.00%
1 Year Changen/a
3 Year Change64.29%
5 Year Change245.86%
Change since IPO391.98%

Recent News & Updates

Eurofins-Cerep SA (EPA:ALECR) Screens Well But There Might Be A Catch

Sep 28
Eurofins-Cerep SA (EPA:ALECR) Screens Well But There Might Be A Catch

Recent updates

Eurofins-Cerep SA (EPA:ALECR) Screens Well But There Might Be A Catch

Sep 28
Eurofins-Cerep SA (EPA:ALECR) Screens Well But There Might Be A Catch

Shareholder Returns

ALECRFR Life SciencesFR Market
7D0%3.6%-0.4%
1Yn/a-3.8%10.6%

Return vs Industry: Insufficient data to determine how ALECR performed against the French Life Sciences industry.

Return vs Market: Insufficient data to determine how ALECR performed against the French Market.

Price Volatility

Is ALECR's price volatile compared to industry and market?
ALECR volatility
ALECR Average Weekly Movement2.2%
Life Sciences Industry Average Movement6.2%
Market Average Movement4.3%
10% most volatile stocks in FR Market10.0%
10% least volatile stocks in FR Market2.2%

Stable Share Price: ALECR has not had significant price volatility in the past 3 months.

Volatility Over Time: ALECR's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989209Antoine Duthilleulhttps://www.eurofins.fr/cerep/

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company’s research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014.

Eurofins-Cerep SA Fundamentals Summary

How do Eurofins-Cerep's earnings and revenue compare to its market cap?
ALECR fundamental statistics
Market cap€116.01m
Earnings (TTM)€11.52m
Revenue (TTM)€47.65m

10.1x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALECR income statement (TTM)
Revenue€47.65m
Cost of Revenue€24.01m
Gross Profit€23.64m
Other Expenses€12.11m
Earnings€11.52m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.28k
Gross Margin49.61%
Net Profit Margin24.19%
Debt/Equity Ratio0.009%

How did ALECR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.